BCV announced today that the company has secured €6 million in a Series A round of financing led by New-York based Forepont Capital Partners, an international venture capital firm investing in disruptive biotech & medtech start-ups.

BCV announced today that the company has secured €6 million in a Series A round of financing led by New-York based Forepont Capital Partners, an international venture capital firm investing in disruptive biotech & medtech start-ups.

BCV announced today that the company has secured €6 million in a Series A round of financing led by New-York based Forepont Capital Partners, an international venture capital firm investing in disruptive biotech & medtech start-ups.

Entwicklung des ersten mechatronischen Führungsdrahtes aus einer Formgedächtnislegierung zur Verbesserung des endovaskulären Zugangs und der Navigation bei minimalinvasiven Eingriffen

BCV Raises €6M Series A

BCV announced today that the company has raised €6 million in a Series A financing round led by FOREPONT CAPITAL PARTNERS, a New York-based international venture capital firm investing in biotech and disruptive medical technology start-ups. Other investors include NTI, based in Palo Alto, MEDCO, based in France, and several early-stage French investors. This Series A financing brings the total amount raised since the creation of BCV to 13 million euros.

Nitinol Based Active Guidewire by BCV, an interview of Eliane Orng, Clinical Affairs Manager at BCV (French language)

Basecamp Vascular, the start-up that will revolutionize the treatment of stroke victims (French article)

Basecamp Vascular (BCV) has announced the appointment of Thierry Col as its new CEO, effective 1 February 2023.

“Physicians face many challenges with neurovascular pathologies in navigating to the treatment site rapidly and safely,” said Michel Piotin. “Through its design versatility and electronic navigation, this actable guide wire facilitates the management of complex arterial maneuvers, saving time and minimizing device exchanges…”

BCV is a medical device company founded in 2016 with the mission to improve patient outcomes by providing simpler, faster and safer navigation for endovascular procedures.

BCV Announces First-In-Human Cases Aimed at Increased Procedural Speed and Reduced Complication in Neurovascular Procedures

“Because ‘time is brain,’ at BCV we developed a sterile, Class III single-use steerable mechatronic guidewire intended to facilitate the access and positioning of a catheter to reach the obstructing clot” said Dr Raphaël Blanc, CEO of BCV.

BCV has today announced major step in the development and evaluation of steerable mechatronic guidewires for stroke treatment. The first-in-human case was conducted by Michel Piotin, MD, PhD, head of Interventional neuroradiology at Foundation Rothschild Hospital in Paris, France.

Basecamp Vascular SAS reported first-in-human trials using a system of steerable mechatronic guidewires for stroke indications.

Basecamp Vascular announces First-In-Human cases with steerable mechatronic guidewire

BCV Announces First-In-Human Cases With its Actuable mechatronic guide wire aimed at Increased Procedural Speed and Reduced Complication in Neurovascular Procedures

BCV’s Actuable mechatronic guide wire for Neurovascular Procedures Used in First-In-Human Case

BCV Announces First-In-Human Cases with its Actuable mechatronic guide wire Aimed at Increased Procedural Speed and Reduced Complication in Neurovascular Procedures

Fin novembre 2021, l’entreprise parisienne Basecamp Vascular, qui a mis au point un cathéter intelligent pour le traitement des accidents vasculaires cérébraux, a reçu plusieurs membres de la commission européenne…

[VIVA TECH 2022] BASECAMP VASCULAR, MAGIC LEMP ET QUANDELA : NOTRE ÉCOSYSTÈME DEEP TECH A DU TALENT !

Suite à la visite d’une délégation FEDER à l’hôpital de la Fondation Rothschild

BCV au CES LAS VEGAS

Basecamp Vascular présente une solution innovante pour améliorer le traitement de l’AVC

Basecamp Vascular : optimiser les interventions en cas d’AVC

Basecamp Vascular dévoile son innovation de rupture : une solution micro-robotique de navigation endovasculaire pour faciliter le traitement des AVC

CES LAS VEGAS les 16 start-ups d’Ile de France parties avec la région à Las Vegas

Ce cathéter « intelligent » pourrait aider à mieux traiter les AVC

La SRC Statice contribue au développement des dispositifs de navigation endovasculaire active de Basecamp Vascular

CurveControl : trouver le bon filon

MedTech : Basecamp Vascular s’implante à Reims

La société Basecamp Vascular est née du constat que les cathéters utilisés pour les procédures vasculaires interventionnelles sont de par leur longueur et leur souplesse peu contrôlables…

Trois start-up accompagnées par la SATT Lutech sont aujourd’hui parmi les 13 lauréats du programme Next French HealthCare

Une nouvelle technologie médicale pour améliorer le traitement des AVC

Catheters for INR operated by Shape Memory Alloys

BaseCamp Vascular pour sa part a développé un système robotique de navigation vasculaire afin de faciliter le traitement par thrombectomie des Accidents Vasculaires Cérébraux (AVC)…

13 start-up s’envolent à la conquête du marché américain de la santé avec Business France

Thrombectomie : le cathéter qui fléchit pour mieux traiter les AVC

CAMI soutient la société BaseCamp Vascular à travers le “Coup de pouce” ECCAMI.